Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco researchers joined by physicians from UCSF Health.

20 Jul 2017

Engineered macrophages invade and engulf tumor cells in mouse models

One reason cancer is so difficult to treat is that it avoids detection by the body. Agents of the immune system are constantly checking the surfaces of cells for chemical signals that say they belong, but cancer cells express the same chemical signals as healthy ones.

19 Jul 2017

Study shows how cancer cells force normal cells to act like viruses to enable tumor growth

In a study that could explain why some breast cancers are more aggressive than others, researchers say they now understand how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.

19 Jul 2017

Researchers discover reason for chemoresistance in small cell lung cancer

Approximately one year after successful treatment with cytotoxic chemotherapy and radiotherapy, patients with advanced Small Cell Lung Cancer (SCLC), which primarily affects heavy smokers, generally relapse with recurrence of tumours that are resistant to further chemotherapy.

18 Jul 2017

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

18 Jul 2017

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

Moffitt Cancer Center researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery (neoadjuvant) or after surgery (adjuvant).

17 Jul 2017

Scientists develop portable device for detecting circulating tumor cells

Researchers at the URV's Department of Physical and Inorganic Chemistry, led by the ICREA researcher, Ramon Álvarez Puebla, and the professor of Applied Physics, Francesc Díaz, and the Department of Clinical Oncology of the HM Torrelodones University Hospital, have patented a portable device that can detect tumor cells in blood.

17 Jul 2017

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels.

14 Jul 2017

Feinstein Institute professor finds protein as potential cause for lupus

Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus.

14 Jul 2017

Beaumont Health's new Proton Therapy Center starts treating cancer patients

Bill Baker, an 86-year-old Mid-Michigan man with brain cancer, is the first patient to receive treatment at Beaumont Health's new Proton Therapy Center at Beaumont Hospital in Royal Oak, Michigan.

13 Jul 2017

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients.

13 Jul 2017

ASTRO releases updated insurance coverage recommendations for proton beam therapy to treat cancer

The American Society for Radiation Oncology has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer.

13 Jul 2017

Pharma, biotech and healthcare industries gender gap

The pharma and biotech industry continues to struggle to make progress with gender diversity. A recent Credit Suisse report shows that management diversity, as defined by percentage of women in senior management roles, has decreased globally from 18.9 percent in 2014 to 15.5 percent in 2016.

13 Jul 2017

Study assesses success and efficacy of ovarian tissue freezing

Many women are turning to egg freezing to promote fertility, but what happens when it isn't an option because of special medical or other conditions? And, what option is there for women who want to preserve hormonal function, not just fertility?

13 Jul 2017

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report in the journal Leukemia.

13 Jul 2017

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

13 Jul 2017

New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.

13 Jul 2017

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.

12 Jul 2017

Study shows potential of whole genome sequencing and AI to help clinicians scale precision oncology

In a study published today in the July 11, 2017 issue of Neurology Genetics, an official journal of the American Academy of Neurology, researchers at the New York Genome Center, The Rockefeller University and other NYGC member institutions, and IBM have illustrated the potential of IBM Watson for Genomics to analyze complex genomic data from state-of-the-art DNA sequencing of whole genomes.

11 Jul 2017

Study uncovers new genetic variants for lung cancer risk

A new study conducted by an international team of lung cancer researchers, including Professor John Field from the University of Liverpool, have identified new genetic variants for lung cancer risk.

10 Jul 2017

Oncology News and Research

Further Reading

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Engineered macrophages invade and engulf tumor cells in mouse models

Study shows how cancer cells force normal cells to act like viruses to enable tumor growth

Researchers discover reason for chemoresistance in small cell lung cancer

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

Study: Breast cancer patients receiving neoadjuvant radiation have lower risk of second primary tumor

Scientists develop portable device for detecting circulating tumor cells

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

Feinstein Institute professor finds protein as potential cause for lupus

Beaumont Health's new Proton Therapy Center starts treating cancer patients

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

ASTRO releases updated insurance coverage recommendations for proton beam therapy to treat cancer

Pharma, biotech and healthcare industries gender gap

Study assesses success and efficacy of ovarian tissue freezing

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Study shows potential of whole genome sequencing and AI to help clinicians scale precision oncology

Study uncovers new genetic variants for lung cancer risk

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News